Coverage
-
March 09, 2012
Eli Lilly & Co. on Friday ended its New Jersey federal court suit against Zydus Pharmaceuticals USA Inc. as the companies reached an agreement resolving Eli Lilly's claims that the generics maker infringed its patented attention deficit hyperactivity disorder drug.
1 other articles on this case.
View all »